101 related articles for article (PubMed ID: 158450)
1. Selective defects in T cell function in ataxia-telangiectasia.
Levis WR; Dattner AM; Shaw JS
Clin Exp Immunol; 1979 Jul; 37(1):44-9. PubMed ID: 158450
[TBL] [Abstract][Full Text] [Related]
2. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
4. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
Nelson DL; Biddison WE; Shaw S
J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
[TBL] [Abstract][Full Text] [Related]
5. Defective specific antiinfluenza virus antibody production in vitro by lymphocytes from patients with ataxia-telangiectasia.
Yarchoan R; Kurman CC; Nelson DL
Kroc Found Ser; 1985; 19():315-29. PubMed ID: 3877788
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases.
Mawas C; Sasportes M; Charmot D; Christen Y; Dausset J
Clin Exp Immunol; 1975 Apr; 20(1):83-92. PubMed ID: 128428
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
8. Analysis of CD3 antigen expression in patients with ataxia-telangiectasia.
Boutin B; Wagner DK; Nelson DL
Clin Exp Immunol; 1987 May; 68(2):320-30. PubMed ID: 3115644
[TBL] [Abstract][Full Text] [Related]
9. Defective activation of the alternative pathway of complement in two brothers with ataxia-telangiectasia.
Saint-Remy JM; Dent RG; Cole P
J Clin Lab Immunol; 1981 Nov; 6(3):221-6. PubMed ID: 7338883
[TBL] [Abstract][Full Text] [Related]
10. Low thymic output and reduced heterogeneity of alpha/beta, but not gamma/delta, T lymphocytes in infants with ataxia-telangiectasia.
Micheli R; Pirovano S; Calandra G; Valotti M; Plebani A; Albertini A; Imberti L
Neuropediatrics; 2003 Jun; 34(3):165-7. PubMed ID: 12910443
[TBL] [Abstract][Full Text] [Related]
11. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
Engleman EG; McDevitt HO
J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
[TBL] [Abstract][Full Text] [Related]
12. Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members.
Lahat N; Zelnik N; Froom P; Kinarty A; Etzioni A
Clin Exp Immunol; 1988 Oct; 74(1):32-5. PubMed ID: 2851398
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
[TBL] [Abstract][Full Text] [Related]
14. Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis.
Evans RL; Lazarus H; Penta AC; Schlossman SF
J Immunol; 1978 Apr; 120(4):1423-8. PubMed ID: 147908
[TBL] [Abstract][Full Text] [Related]
15. Role of the LFA-1 molecule in cellular interactions required for antibody production in humans.
Fischer A; Durandy A; Sterkers G; Griscelli C
J Immunol; 1986 May; 136(9):3198-203. PubMed ID: 3514755
[TBL] [Abstract][Full Text] [Related]
16. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
Hahn T; Levin S; Handzel ZT
Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
[TBL] [Abstract][Full Text] [Related]
17. Defective allosuppression in patients with ataxia-telangiectasia.
Tosato G; Blaese RM
Kroc Found Ser; 1985; 19():331-8. PubMed ID: 2999344
[TBL] [Abstract][Full Text] [Related]
18. Blastogenic factor: its role in the mixed leukocyte culture reaction.
Uotila M; Rode HN; Gordon J
Eur J Immunol; 1978 Feb; 8(2):133-8. PubMed ID: 149007
[TBL] [Abstract][Full Text] [Related]
19. Human intestinal mononuclear cells. II. Demonstration of a naturally occurring subclass of T cells which respond in the allogeneic mixed leukocyte reaction but do not effect cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Jenkins KM; Franklin GO; Shedlofsky S; Kodner IJ
Gastroenterology; 1981 Apr; 80(4):748-57. PubMed ID: 6451470
[TBL] [Abstract][Full Text] [Related]
20. Intact T cell responses in ataxia telangiectasia.
Pashankar F; Singhal V; Akabogu I; Gatti RA; Goldman FD
Clin Immunol; 2006 Aug; 120(2):156-62. PubMed ID: 16762595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
